Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.

Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.

Item
http://www.wikidata.org/entity/Q34103866
Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cellsAntigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.Common gamma chain cytokines promote rapid in vitro expansion of allo-specific human CD8+ suppressor T cellsTolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant toleranceTolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation.Engineering antigens for in situ erythrocyte binding induces T-cell deletion.Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease.Exploiting apoptosis for therapeutic tolerance induction.Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy.In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.Overcoming immunological barriers in regenerative medicine.Harnessing Apoptotic Cells for Transplantation Tolerance: Current Status and Future Perspectives.Differential Role of B Cells and IL-17 Versus IFN-γ During Early and Late Rejection of Pig Islet Xenografts in Mice.An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
P2860

Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.

Item
http://www.wikidata.org/entity/Q34103866
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@ast
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@en
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@nl
type
label
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@ast
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@en
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@nl
prefLabel
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@ast
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@en
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Ethylenecarbodiimide-treated s ...... inhibiting CD154 upregulation.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932